MIRA INFORM REPORT

 

 

Report Date :

09.05.2012

 

IDENTIFICATION DETAILS

 

Name :

STELLENCE PHARMSCIENCE PRIVATE LIMITED (w.e.f. 13.12.2011)

 

 

Formerly Known As :

STELLENCE PHARMSCIENCE LIMITED (w.e.f. 01.04.2010)

KARNATAKA CHEMSYN LIMITED

 

 

Registered Office :

No.456, 1A and 1B, Industrial Area, Jigani, Bangalore-562106, Karnataka

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

01.01.1992

 

 

Com. Reg. No.:

08-012673

 

 

Capital Investment / Paid-up Capital :

Rs.147.008 Millions

 

 

CIN No.:

[Company Identification No.]

U85110KA1992PLC012673

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BLRK07078B

 

 

PAN No.:

[Permanent Account No.]

AABCK9903A

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Niche Pharmaceutical Products like Contrast Media Agents.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (26)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 2500000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. There appear huge accumulated losses recorded by the company. However, trade relations are reported as fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

LOCATIONS

 

Registered Office :

No.456, 1A and 1B, Industrial Area, Jigani, Bangalore-562106, Karnataka, India 

Tel. No.:

91-8110-413887

Fax No.:

Not Available

E-Mail :

niranjan.p@avignapharma.com

 

 

DIRECTORS

 

AS ON 30.09.2011

 

Name :

Dr. Francis Joseph Pinto

Designation :

Director

Address :

6, Clarence Terrace, Regents Park, London – NWlRD, United Kingdom

Date of Birth/Age :

03.11.1942

Date of Appointment :

23.08.2006

DIN No.:

01844138

 

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U55101GA1995PTC001897

Mayfair Eco Resorts Private Limited

Director

18-07-95

18-07-95

-

Active

YES

2

U63040MH1999PTC120045

Santosh India Opertions Private Limited

Director

26-05-99

26-05-99

20-04-11

Active

NO

3

U01122GA1998PTC003428

Valpoi Valley Botanicals Private Limited

Director

08-01-01

08-01-01

-

Active

YES

4

U24239MH2001PTC130422

Farmacross India Private Limited

Director

17-04-01

17-04-01

16-04-09

Active

NO

5

U32107MH2001PTC132041

Infocross India Private Limited

Director

03-10-01

03-10-01

-

Active

YES

6

U72200GA2006PTC004325

Open Destination Infotech Private Limited

Director

05-01-06

05-01-06

-

Active

NO

7

U85110KA1992PLC012673

Stellence Pharmscience Limited

Director

23-08-06

23-08-06

-

Active

NO

8

U24231KA2005PTC035805

Avigna Chemitech Private Limited

Director

23-08-06

23-08-06

-

Active

NO

9

U72900MH2007PTC169715

ShawMan Software Private Limited

Director

30-09-09

10-06-08

-

Active

YES

10

U55101MH2008PLC185253

Bona Sera Hotels Limited

Director

04-06-09

16-04-09

-

Active

NO

11

U55101MH2009PLC190137

Sol Hospitality Limited

Director

16-04-09

16-04-09

-

Active

NO

12

U63040GA2009PTC006157

Destination Insider Travels India Private Limited

Director

10-08-09

10-08-09

-

Active

NO

13

U72200KA2009PTC048836

ChiHealth Wellness Solutions (Bangalore) Private Limited

Director

25-09-10

25-09-10

08-09-11

Active

NO

 

 

Name :

Mr. Ramachandran Radhakrishnan

Designation :

Director

Address :

Block B1, Flat Number 1202 L and T, South city, Arakere Micolayout, Bangalore – 560076, Karnataka, India

Date of Appointment :

23.08.2006

DIN No.:

00326368

 

Other Directorship:

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24231KA2005PTC035805

Avigna Chemitech Private Limited

Director

11-03-05

11-03-05

-

Active

NO

2

U67190KA2005PTC037009

East West Capital Partners India Private Limited

Director

18-08-05

18-08-05

-

Active

NO

3

U85110KA1992PLC012673

Stellence Pharmscience Limited

Director

23-08-06

23-08-06

-

Active

NO

4

U29299KA2007PTC042079

Xenocor Pharmalab Private Limited

Director

13-03-07

13-03-07

10-05-10

Active

NO

5

U72200KA2009PTC048836

ChiHealth Wellness Solutions (Bangalore) Private Limited

Director

25-09-10

25-09-10

08-09-11

Active

NO

 

Name :

Mrs. Anuradha Ramchandran

Designation :

Additional Director

Address :

Block B1, Flat Number 1202 L and T, South city, Arakere Micolayout, Bangalore – 560076, Karnataka, India

Date of Appointment :

26.10.2010

DIN No.:

00326388

 

Other Directorship:

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U24231KA2005PTC035805

Avigna Chemitech Private Limited

Director

11-03-05

11-03-05

-

Active

NO

2

U67190KA2005PTC037009

East West Capital Partners India Private Limited

Director

31-03-07

31-03-07

-

Active

NO

3

U85110KA1992PTC012673

Stellence Pharmscience Private Limited

Additional director

26-10-10

26-10-10

-

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2011

 

Names of Shareholders

No. of Equity  Shares

No. of Preference   Shares

Avigna Chemitech Private Limited, India

365500

1370000

Venugopalan Nair

134500

--

Ramachandran Radhakrishnan

40

--

Anuradha Ramachandran

10

--

Aditi Ramachandran

10

--

Ashwini Ramachandran

10

--

K P Rema

200000

--

Vidhyasagaran C P

150000

--

Padikkaveetil Bhavdasan

150700

--

Total

1000770

1370000

 

AS ON 30.09.2011

 

Equity Shares Break Up

Percentage

Bodies Corporate

37.00

Directors or relatives of Directors

63.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Niche Pharmaceutical Products like Contrast Media Agents.

 

 

GENERAL INFORMATION

 

Bankers :

·         State Bank of India, J P Nagar, I Phase, Main Road, Banglore-560078, Karnataka,  India

·         IDBI Bank, Mumbai-400027, Maharashtra, India

·         Centurion Bank of Punjab Limited

 

 

Facilities :

Secured Loan

 

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

 

 

 

State Bank of India – Term Loan

139.992

138.002

State Bank of India – EPC

16.043

23.089

State Bank of India –CC

4.629

(0.520)

State Bank of India –Bill Discount

0.000

4.450

Centurion Bank of Punjab Limited – Car Loan

0.313

0.476

Sriram Finance Limited – Tata Ace Loan

0.198

0.000

Total

161.175

165.497

 

 

 

Unsecured Loan

 

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

 

 

 

From Inter Corporate Loans / members

202.909

194.459

Total

202.909

194.459

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

P Chandrasekar

Chartered Accountant

Address :

S-616, Manipal Centre, No.47, Dickenson Road, Bawngalore-560042, Karnataka, India

Tel. No.:

91-80-25585443

Telfax No.:

91-80-25597494

E-Mail :

partner@pchandrasekar.com

PAN No.:

AABFP1536H

 


 

CAPITAL STRUCTURE

 

AS ON 31.03.2011

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

1300000

Equity Shares

Rs.10/- each

Rs.13.000 Millions

1370000

6% Convertible Preference Shares

Rs. 100/- each

Rs.137.000 Millions

 

Total

 

Rs.150.000 Millions

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

1000770

Equity Shares

Rs.10/- each

Rs. 10.008 Millions

1370000

Preference Shares

Rs. 100/- each

Rs.137.000 Millions

 

Total

 

Rs.147.008 Millions

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

147.008

72.008

10.008

2] Share Application Money

1.292

1.292

3.292

3] Reserves & Surplus

544.206

1.500

1.500

4] (Accumulated Losses)

(75.475)

(64.849)

(54.889)

NETWORTH

617.031

9.951

(40.089)

LOAN FUNDS

 

 

 

1] Secured Loans

161.175

165.497

64.231

2] Unsecured Loans

202.909

194.459

230.858

TOTAL BORROWING

364.084

359.956

295.089

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

981.115

369.907

255.000

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

922.180

163.971

168.380

CAPITAL WORK-IN-PROGRESS

4.339

171.444

60.410

PRE-OPERATIVE PENDING CAPITALISATION

0.000

14.329

14.329

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

39.436
28.905

9.945

 

Sundry Debtors

72.071
30.319

7.844

 

Cash & Bank Balances

4.329
3.003

2.070

 

Other Current Assets

0.000
0.000

0.000

 

Loans & Advances

13.981
16.359

13.447

Total Current Assets

129.817
78.586

33.306

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

72.536
54.720

18.643

 

Other Current Liabilities

2.335
3.353

2.168

 

Provisions

0.350
0.350

0.614

Total Current Liabilities

75.221
58.423

21.425

Net Current Assets

54.596
20.163

11.881

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

981.115

369.907

255.000

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Sales

163.099

71.211

21.238

 

 

Other Income

1.221

0.654

0.587

 

 

TOTAL                                     (A)

164.320

71.865

21.825

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Materials Cost

113.492

35.543

16.420

 

 

Personnel Expenses

16.131

17.198

6.785

 

 

Manufacturing, Administrative and Selling  Expenses

28.122

20.229

10.648

 

 

Increase / (Decrease) in Stock

(6.805)

(4.425)

(0.645)

 

 

TOTAL                                     (B)

150.940

68.545

33.208

 

 

 

 

 

Less

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

13.380

3.320

(11.383)

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

9.676

2.721

0.980

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

3.704

0.599

(12.363)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

14.330

10.559

7.357

 

 

 

 

 

 

PROFIT / (LOSS)BEFORE TAX (E-F)                  (G)

(10.626)

(9.960)

(19.720)

 

 

 

 

 

Less

TAX                                                                  (H)

0.000

0.000

0.350

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX (G-H)                  (I)

(10.626)

(9.960)

(20.070)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(64.848)

(54.888)

(34.818)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(75.474)

(64.848)

(54.888)

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

(4.48)

(9.95)

(20.05)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

(6.47)
(13.86)

(91.96)

 

 

 
 

 

Net Profit Margin

(PBT/Sales)

(%)

(6.52)
(13.99)

(92.85)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(1.01)
(4.11)

(9.78)

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.02)
(1.00)

0.49

 

 

 
 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.71
42.04

(7.90)

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

1.73
1.35

1.55

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

No

5) Type of Business

Yes

6) Line of Business•

Yes

7) Promoter’s background

Yes

8) No. of employees

No

9) Name of person contacted

No

10) Designation of contact person

No

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

No

15) Capital in the business

Yes

16) Details of sister concerns

No

17) Major suppliers

No

18) Major customers

No

19) Payments terms

No

20) Export / Import details (if applicable)

No

21) Market information

--

22) Litigations that the firm / promoter

--

23) Banking Details

Yes

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

 

FORM 8

 

Corporate identity number of the company

U85110KA1992PLC012673

Name of the company

KARNATAKA CHEMSYN LIMITED

Address of the registered office or of the principal place of  business in India of the company

No.456, 1A and 1B, Industrial Area, Jigani, Bangalore-562106, Karnataka, India 

This form is for

Creation of charge

Type of charge

Immovable property

Others

Particular of charge holder

State Bank of India, J P Nagar, I Phase, Main Road, Banglore-560078, Karnataka,  India

Nature of instrument creating charge

1.Equitbale Mortgage of Properties

2.Hypothecation Agreement of Goods and Assets

3.Term Loan Agreement

Date of instrument Creating the charge

08.08.2008

Amount secured by the charge

Rs. 190.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest

12.75 %

Margin 25%

 

Terms of repayment

Repayable on demand 2.000 millions monthly installments for term loan

 

Margin

25%

Short particulars of the property charged (Including location of the property)

Sy No.456/1b Property  No.502 Measuring 1 Acre @ Jigani Village Anekal Taluk Bangalore

456/1b Property No.502 Measuring 13 Guntas

456/1b Property No.503 Measuring 1 Acre

456/1b Property No.503 Measuring 1 Acre

456/1a Property No.503 Measuring 5 Guntas

456/Aa Property No.503 Measuring 2 Acres

Hypothecation  of Goods and Assets, Present and Future ,  Book Debts and Other Movable Assets Documents to Title to Goods, Receivables, Outstanding Monies Etc

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Office Equipments

·         Computers

·         Furniture and Fixtures

·         Technical Knwohow

·         Motor Vehicles

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.86

UK Pound

1

Rs.85.44

Euro

1

Rs.68.81

 

 

INFORMATION DETAILS

 

Report Prepared by :

BSN


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

2

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

26

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.